CT Antigen TCR-redirected T Cells for Ovarian Cancer.
Study Number: 

I 230612

Phase: 
Early Phase
Trial categories: 
Ovarian/Peritoneal/Fallopian
Gynecologic Cancer
Early Phase Clinical Trial
Principal Investigator: